Role of Baseline pol Genotype in HIV-1 Fitness Evolution
- 1 August 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 33 (4) , 448-460
- https://doi.org/10.1097/00126334-200308010-00005
Abstract
Viral fitness can be modified upon development of antiretroviral drug resistance, usually by selection of compensatory mutations. In this study, we have used HIV-1 isolates from individuals receiving a protease inhibitor (PI)-based regimen to analyze the impact of basal genetic background on viral fitness evolution. Paired plasma samples and HIV-1 isolates were obtained from 10 PI-naive HIV-infected individuals enrolled in 2 different studies of combination antiretroviral therapy. Genomic regions from pol and env were sequenced. Viral fitness was measured using growth competition experiments followed by heteroduplex tracking analysis. Baseline genotypic analyses of pol showed that 9 of 10 viruses had a different degree of secondary mutations in the protease gene at codons associated with PI resistance (i.e., 10I, 36I, 63P, 71T, and 77I). After 48 weeks of PI-based therapy, a strong correlation was observed between protease genetic divergence and viral fitness difference (r = 0.78, P = 0.03), but not with reverse transcription or Env divergence, suggesting that genotypic changes in the protease gene were driving HIV-1 evolution in these patients. As expected, an inverse correlation was observed between the number of protease and reverse transcription primary mutations and viral fitness (r = −0.65, PKeywords
This publication has 59 references indexed in Scilit:
- Prevalence of antiretroviral resistance in a South London cohort of treatment-naive HIV-1-infected patientsAIDS, 2001
- Implications of antiretroviral resistance on viral fitnessCurrent Opinion in Infectious Diseases, 2001
- Antiretroviral Drug Resistance Testing in Adult HIV-1 InfectionJAMA, 2000
- Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapyAIDS, 2000
- HIV drug resistance and viral fitnessPublished by Elsevier ,2000
- Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapyAIDS, 1999
- HIV-1 evolution under pressure of protease inhibitors: Climbing the stairs of viral fitnessJournal of Biomedical Science, 1999
- Antiretroviral Drug Resistance Testing in Adults With HIV InfectionJAMA, 1998
- Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.Proceedings of the National Academy of Sciences, 1996
- HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and TherapyScience, 1995